Kodai Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Kodai Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$4.12M	Buy	+185,364	New	+$3.82M	0.16%	111

Other funds holding KNSA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kodai Capital Management's KNSA Position: Q1 2025 in Review

Kodai Capital Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q1 2025: 185,364 shares worth $4.12M. The stake represents 0.16% of the portfolio and ranks #111 among its holdings.

176 funds tracked by Wall St. Rank hold KNSA as of Q1 2025.

Kodai Capital Management held 185,364 shares of Kiniksa Pharmaceuticals worth $4.12M as of Q1 2025.
Kiniksa Pharmaceuticals was a new Kodai Capital Management position in Q1 2025.
Kiniksa Pharmaceuticals made up 0.16% of Kodai Capital Management's portfolio in Q1 2025, its #111 holding.
176 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2025.

Based on Kodai Capital Management's 13F filing for Q1 2025, filed 15 May 2025.